Latest Breaking News On - Nontuberculous mycobacterial - Page 1 : comparemela.com

Inaugural World NTM Awareness Day Marks 20-Year Anniversary and Honors Founders' Mission on August 4, 2023

/PRNewswire/ NTM Info & Research (www.ntminfo.org), a pioneering global organization committed to addressing NonTuberculous Mycobacterial (NTM) and.

Insmed Presents Range of New Study Findings at American Thoracic Society 2023 International Conference

Brensocatib Reduced Risk of Exacerbations Irrespective of Disease Severity in Patients with Non-Cystic Fibrosis Bronchiectasis (NCFBE) in Phase 2 WILLOW.

Insmed to Present New Clinical, Pre-Clinical, and Real-World Data in Serious and Rare Lung Diseases at the American Thoracic Society 2023 International Conference

Insmed to Present New Clinical, Pre-Clinical, and Real-World Data in Serious and Rare Lung Diseases at the American Thoracic Society 2023 International Conference

/PRNewswire/ Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare.

RedHill Receives USPTO Notice of Allowance for a Patent Covering Phase 3-stage RHB-204 for the Treatment of NTM Disease

RedHill Receives USPTO Notice of Allowance for a Patent Covering Phase 3-stage RHB-204 for the Treatment of NTM Disease - read this article along with other careers information, tips and advice on BioSpace